QT
LRMR icon

Quantbot Technologies’s Larimar Therapeutics LRMR Stock Holding History

Quantbot Technologies’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
68,771
+68,440
+20,677% +$272K 0.01% 1251
2026
Q1 		$1.49K Buy
+331
New +$1.32K ﹤0.01% 1618
2016
Q2 		– Sell
-238
Closed -$19K – 1219
2016
Q1 		$19K Sell
238
-266
-53% -$21K ﹤0.01% 1011
2015
Q4 		$38K Buy
+504
New +$81K 0.01% 849
2015
Q2 		– Sell
-153
Closed -$72K – 1260
2015
Q1 		$72K Buy
+153
New +$72.6K 0.02% 697

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Quantbot Technologies's LRMR Position: Q2 2026 in Review

Quantbot Technologies increased its Larimar Therapeutics (LRMR) stake by 20,677% in Q2 2026, buying an estimated $272K and bringing the position to 68,771 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #1251.

Quantbot Technologies first reported a position in LRMR in Q1 2015 and has held it in 5 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Quantbot Technologies held 68,771 shares of Larimar Therapeutics worth $210K as of Q2 2026.
  • Quantbot Technologies bought 68,440 Larimar Therapeutics shares in Q2 2026, an estimated $272K.
  • Larimar Therapeutics made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1251 holding.
  • Quantbot Technologies first reported a position in Larimar Therapeutics in Q1 2015 and has held it in 5 quarters since.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.